£86.15

It has never been this cheap. We have no record of a lower price.

£86 today · cheaper than every other day in the last 3 months

Springer Antibody-Drug Conjugates: The 21st Century Magic Bullets for Cancer: 17 (AAPS Advances in the Pharmaceutical Sciences Series)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 64 days · 64 data points (no recent data)

Historical
Generating forecast…
£86.15 £81.84 £83.57 £85.29 £87.01 £88.73 £90.46 22 August 2026 06 September 2026 22 September 2026 08 October 2026 24 October 2026
View at Amazon ↗

Price data last checked 27 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 64 days • 1 price levels

Days at Price
64 days 0 16 32 48 64 £86 Days at Price

Price Analysis

Most common price: £86 (64 days, 100.0%)

Price range: £86 - £86

Price levels: 1 different prices over 64 days

Description

This authoritative volume provides a holistic picture of antibody-drug conjugates (ADCs). Fourteen comprehensive chapters are divided into six sections including an introduction to ADCs, the ADC construct, development issues, landscape, IP and pharmacoeconomics, case studies, and the future of the field. The book examines everything from the selection of the antibody, the drug, and the linker to a discussion of developmental issues such as formulations, bio-analysis, pharmacokinetic-pharmacodynamic relationships, and toxicological and regulatory challenges. It also explores pharmacoecomonics and intellectual properties, including recently issued patents and the cost analysis of drug therapy. Case studies are presented for the three ADCs that have received FDA approval: gemtuzumab ozogamicin (Mylotarg®), Brentuximab vedotin (Adcetris®), and ado-trastuzumab emtansine (Kadcyla®), as well as an ADC in late-stage clinical trials, glembatumumab vedotin (CDX-011). Finally, the volume presents a perspective by the editors on the future directions of ADC development and clinical applications. Antibody-Drug Conjugates is a practical and systematic resource for scientists, professors, and students interested in expanding their knowledge of cutting-edge research in this exciting field.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
06 October 2016
Listed Since
29 September 2016

Barcode

No barcode data available

Similar Products You Might Like

Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins (Milestones in Drug Therapy)
86% match

Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins (Milestones in Drug Therapy)

Springer

£108.78 22 Oct 2026
Recombinant Antibodies for Cancer Therapy: Methods and Protocols: 207 (Methods in Molecular Biology, 207)
80% match

Recombinant Antibodies for Cancer Therapy: Methods and Protocols: 207 (Methods in Molecular Biology, 207)

Humana

£80.67 23 Oct 2026
Current Applications for Overcoming Resistance to Targeted Therapies: 20 (Resistance to Targeted Anti-Cancer Therapeutics, 20)
79% match

Current Applications for Overcoming Resistance to Targeted Therapies: 20 (Resistance to Targeted Anti-Cancer Therapeutics, 20)

Springer

£76.42 26 Oct 2026
Enzyme-Prodrug Strategies for Cancer Therapy
79% match

Enzyme-Prodrug Strategies for Cancer Therapy

Springer

£149.87 23 Oct 2026
Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)
79% match

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Springer

£112.59 28 Oct 2026
Capillary Electrophoresis-Mass Spectrometry: Therapeutic Protein Characterization
79% match

Capillary Electrophoresis-Mass Spectrometry: Therapeutic Protein Characterization

Springer

£92.21 26 Oct 2026
Cellular Therapies for Cancer Treatment: Advancements in Drug Delivery Strategies
79% match

Cellular Therapies for Cancer Treatment: Advancements in Drug Delivery Strategies

Elsevier

£141.99 23 Oct 2026
Drug Targeting Complexity: Tissue-Specific Regulation and Molecular Paradigms in Cancer Therapy
78% match

Drug Targeting Complexity: Tissue-Specific Regulation and Molecular Paradigms in Cancer Therapy

Elsevier

£135.76 22 Oct 2026
Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)
78% match

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Springer

£113.69 24 Oct 2026
Analytical Characterization of Biotherapeutics
78% match

Analytical Characterization of Biotherapeutics

Wiley

£137.97 24 Oct 2026
Pharmacokinetics and Pharmacodynamics of Biotech Drugs: Principles and Case Studies in Drug Development
78% match

Pharmacokinetics and Pharmacodynamics of Biotech Drugs: Principles and Case Studies in Drug Development

Wiley

£126.87 27 Oct 2026
Drug Product Development for the Back of the Eye: 2 (AAPS Advances in the Pharmaceutical Sciences Series, 2)
78% match

Drug Product Development for the Back of the Eye: 2 (AAPS Advances in the Pharmaceutical Sciences Series, 2)

Springer

£147.56 23 Oct 2026
Integrin Targeting Systems for Tumor Diagnosis and Therapy (Methods in Pharmacology and Toxicology)
78% match

Integrin Targeting Systems for Tumor Diagnosis and Therapy (Methods in Pharmacology and Toxicology)

Humana

£69.37 22 Oct 2026
Antibody Engineering: Methods and Protocols, Second Edition: 907 (Methods in Molecular Biology, 907)
78% match

Antibody Engineering: Methods and Protocols, Second Edition: 907 (Methods in Molecular Biology, 907)

Humana

£126.61 23 Oct 2026
Pharmaceutical Perspectives of Cancer Therapeutics
78% match

Pharmaceutical Perspectives of Cancer Therapeutics

Springer

£179.99 27 Oct 2026
Pharmacology of Immunotherapeutic Drugs
78% match

Pharmacology of Immunotherapeutic Drugs

Springer

£73.14 22 Oct 2026
Cancer Gene Therapy by Viral and Non-viral Vectors: 4 (Translational Oncology)
78% match

Cancer Gene Therapy by Viral and Non-viral Vectors: 4 (Translational Oncology)

Wiley

£110.05 21 Oct 2026
NK Cells in Cancer Immunotherapy: Successes and Challenges (Volume 4) (Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy, Volume 4)
78% match

NK Cells in Cancer Immunotherapy: Successes and Challenges (Volume 4) (Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy, Volume 4)

Elsevier

£135.97 23 Oct 2026
Stem Cell Drugs - A New Generation of Biopharmaceuticals (Stem Cells in Clinical Applications)
78% match

Stem Cell Drugs - A New Generation of Biopharmaceuticals (Stem Cells in Clinical Applications)

Springer

£74.77 27 Oct 2026
Cancer Drug Design and Discovery
78% match

Cancer Drug Design and Discovery

Academic Press

£84.99 24 Oct 2026
Gene and Cellular Immunotherapy for Cancer (Cancer Drug Discovery and Development)
77% match

Gene and Cellular Immunotherapy for Cancer (Cancer Drug Discovery and Development)

Humana

£113.77 30 Oct 2026
Nutraceuticals and Cancer
77% match

Nutraceuticals and Cancer

Springer

£113.76 23 Oct 2026
The Challenge of CMC Regulatory Compliance for Biopharmaceuticals
77% match

The Challenge of CMC Regulatory Compliance for Biopharmaceuticals

Springer

£120.74 23 Oct 2026
Development of Antibody-Based Therapeutics: Translational Considerations & Challenges
77% match

Development of Antibody-Based Therapeutics: Translational Considerations & Challenges

Adis

£111.83 24 Oct 2026